dc.contributor.author | Namal, Esat | |
dc.contributor.author | Bozkurt, Mustafa | |
dc.contributor.author | Ozturk, Akin | |
dc.contributor.author | Planci, Kezban Nur | |
dc.contributor.author | Bassullu, Nuray | |
dc.contributor.author | Pamukcu, Ozgul | |
dc.contributor.author | Demir, Gokhan | |
dc.date.accessioned | 2019-08-13T12:10:23Z | |
dc.date.accessioned | 2019-08-13T16:03:08Z | |
dc.date.available | 2019-08-13T12:10:23Z | |
dc.date.available | 2019-08-13T16:03:08Z | |
dc.date.issued | 2013 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.uri | http://hdl.handle.net/11446/3009 | |
dc.description | 49th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 31-JUN 04, 2013 -- Chicago, IL | en_US |
dc.description | WOS: 000335419604655 | en_US |
dc.description.abstract | … | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.language.iso | eng | en_US |
dc.publisher | AMER SOC CLINICAL ONCOLOGY | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.title | Biologic markers guiding the treatment of non-small cell lung cancer: RRM-1, class III beta tubulin, and ERCC-1. | en_US |
dc.type | conferenceObject | en_US |
dc.relation.journal | JOURNAL OF CLINICAL ONCOLOGY | en_US |
dc.department | DBÜ | en_US |
dc.identifier.issue | 15 | en_US |
dc.identifier.volume | 31 | en_US |
dc.contributor.authorID | 0000-0003-2473-4431 | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.department-temp | Istanbul Bilim Univ, Dept Med Oncol, Istanbul, Turkey -- Istanbul Bilim Univ, Sch Med, Dept Med Oncol, Istanbul, Turkey -- Istanbul Bilim Univ, Fac Med, Dept Med Oncol, Istanbul, Turkey -- Istanbul Bilim Univ, Fac Med, Dept Pathol, Istanbul, Turkey -- Istanbul Sisli Etfal Training & Res Hosp, Istanbul, Turkey -- Ufuk Univ, Sch Med, Dept Med Oncol, Ankara, Turkey | en_US |